A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Clinical trial NCT05279131 · COMPLETED

Trial details

NCT number: NCT05279131
Sponsor: Almirall, S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Keratosis, Actinic

Start date: 2022-06-28
Primary completion: 2022-12-28
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.